Cargando…

Evaluation of Multiple System Atrophy Subtypes with FDG-PET

Detalles Bibliográficos
Autor principal:	Jellinger, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513978/ https://www.ncbi.nlm.nih.gov/pubmed/34728935 http://dx.doi.org/10.4103/aian.AIAN_54_21

Ejemplares similares

Multiple system atrophy with hippocampal pathology
por: Jellinger, Kurt A.
Publicado: (2022)

Heterogeneity of Multiple System Atrophy: An Update
por: Jellinger, Kurt A.
Publicado: (2022)

Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy(1)
por: Jellinger, Kurt A.
Publicado: (2018)

Diagnosing Subtypes of Progressive Supranuclear Palsy: Can (18)F-FDG PET/CT Imaging Guide Our Way?
por: Desai, Ishita, et al.
Publicado: (2022)

Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
por: Kaindlstorfer, Christine, et al.
Publicado: (2018)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Clinical features, MRI, and 18F‐FDG‐PET in differential diagnosis of Parkinson disease from multiple system atrophy
por: Zhao, Ping, et al.
Publicado: (2020)

The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?
por: Bitan, Gal
Publicado: (2020)

Evolving role of FDG-PET/CT in prognostic evaluation of resectable gastric cancer
por: De Raffele, Emilio, et al.
Publicado: (2017)

The Neuropathologic Substrate of Parkinson Disease Dementia
por: Jellinger, Kurt A.
Publicado: (2009)

Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy
por: Wei, Jianshe, et al.
Publicado: (2023)

(18)F-FDG PET/CT to predict tumor PD-L1 expression and response to PD-(L)1 blockade in patients with non-small-cell lung cancer
por: Borm, Frank Johannes, et al.
Publicado: (2020)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
por: Alavi, Abass, et al.
Publicado: (2021)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Could [(18)F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
por: Dondi, Francesco, et al.
Publicado: (2022)

Uncertainties in the PET defined A‐/T(Neocortical)+ subtype
por: Mormino, Elizabeth C., et al.
Publicado: (2022)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

Advances in Molecular Medicine: Unravelling Disease Complexity and Pioneering Precision Healthcare
por: Bustin, Stephen A., et al.
Publicado: (2023)

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET
por: Townley, Ryan A, et al.
Publicado: (2021)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Inclusion of brain in FDG PET/CT scanning techniques in cancer patients: Does it obviate the need for dedicated brain imaging?
por: Purandare, Nilendu C
Publicado: (2011)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Relevance of Subtype Classification of PSP
por: Chatterjee, Koustav, et al.
Publicado: (2021)

Commentary on PSP Subtypes in India
por: Behari, Madhuri
Publicado: (2021)

Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges
por: Peng, Shichun, et al.
Publicado: (2020)

(18)F-FDG PET/CT for the diagnosis of aortic inflammation in COVID-19
por: van der Bijl, Pieter, et al.
Publicado: (2022)

Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019)

Gene therapy for spinal muscular atrophy: Solomon's consensus in Covid times
por: Zafeiriou, Dimitrios
Publicado: (2020)

Myasthenia Gravis: Do the Subtypes Matter?
por: Murthy, J. M. K.
Publicado: (2020)

Central autonomic dysfunction in multiple system atrophy: can we measure it with MRI?
por: van Eimeren, Thilo
Publicado: (2020)

Importance of measurement repeatability of semi-quantitative imaging through PET-CT and PET-MR imaging in oncology
por: Priola, Adriano Massimiliano, et al.
Publicado: (2019)

Mild Cognitive Impairment: Beyond Memory Dysfunction
por: Tales, Andrea, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jfcpnh57oo1c4484cagclv2n23